Prestige Consumer Healthcare Stock Forecast
| Recent Prestige Consumer Healthcare Stock Price | Prestige Consumer Healthcare Stock Forecast Price | |
| $58.25 |  +34.59% |
$78.40 |
| Recent Prestige Consumer Healthcare Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 4 | 4 | 4 | 4 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 2 | 2 | 2 | 2 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.67 | 1.67 | 1.67 | 1.67 |
The presented Prestige Consumer Healthcare stock forecast (traded under symbol PBH), for forward-twelve-months price target as shown at the top of this page, gives you the average Prestige Consumer Healthcare stock forecast for forward target price for symbol PBH, across the 5 analysts covering Prestige Consumer Healthcare (PBH), as reported in data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Prestige Consumer Healthcare stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Prestige Consumer Healthcare stock forecast and half had a lower Prestige Consumer Healthcare stock forecast) was $71.0 as of 2023-06-09 (which is a different mathematical metric versus taking the average or mean), while the
highest Prestige Consumer Healthcare stock forecast in the analyst group was $112.0, and the lowest Prestige Consumer Healthcare stock forecast in the analyst group was
$60.0, with a standard deviation of $19.957. Get the latest Zacks research report on PBH — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
||||||||||||||||||||||||
|
|
|
 Free PBH Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Buy (3.33 out of 4) 46th percentile
(ranked lower than approx. 54% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
|
|
